Abionyx Pharma SA
PAR:ABNX
Abionyx Pharma SA
PAR:ABNX
Price:
3.37
EUR
-0.88%
Market Cap:
€119.7m
Cash Flow Statement
Cash Flow Statement
Abionyx Pharma SA
Abionyx Pharma SA
Currency: EUR
| Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(17)
|
(24)
|
(25)
|
(11)
|
(5)
|
(8)
|
(6)
|
(0)
|
2
|
(2)
|
(2)
|
(4)
|
(6)
|
(6)
|
(4)
|
(4)
|
(4)
|
(3)
|
(4)
|
(5)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Other Non-Cash Items |
0
|
3
|
5
|
1
|
(2)
|
(0)
|
1
|
(4)
|
(5)
|
0
|
(1)
|
(1)
|
1
|
1
|
1
|
(0)
|
(1)
|
(1)
|
1
|
1
|
|
| Change in Working Capital |
2
|
3
|
1
|
(3)
|
(2)
|
1
|
(1)
|
(3)
|
(1)
|
1
|
2
|
(1)
|
(2)
|
(2)
|
0
|
1
|
1
|
1
|
(0)
|
0
|
|
| Cash from Operating Activities |
(14)
N/A
|
(19)
-36%
|
(19)
-3%
|
(13)
+30%
|
(9)
+32%
|
(7)
+28%
|
(6)
+9%
|
(6)
-4%
|
(4)
+37%
|
(0)
+90%
|
(1)
-47%
|
(5)
-809%
|
(7)
-23%
|
(6)
+10%
|
(3)
+44%
|
(2)
+31%
|
(4)
-59%
|
(3)
+18%
|
(4)
-20%
|
(3)
+5%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+18%
|
(0)
+96%
|
(0)
-100%
|
(0)
-2 030%
|
(0)
-8%
|
(0)
+96%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-525%
|
(0)
+10%
|
1
N/A
|
1
-8%
|
(0)
N/A
|
(0)
+27%
|
(0)
-2%
|
(0)
+31%
|
(0)
+16%
|
(0)
-179%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
49
|
1
|
1
|
0
|
0
|
(0)
|
1
|
2
|
1
|
(0)
|
2
|
2
|
4
|
4
|
0
|
0
|
4
|
8
|
3
|
(0)
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Cash from Financing Activities |
49
N/A
|
1
-98%
|
1
-8%
|
1
-4%
|
1
+1%
|
(0)
N/A
|
1
N/A
|
2
+95%
|
1
-65%
|
(0)
N/A
|
2
N/A
|
2
+1%
|
4
+153%
|
4
-1%
|
(0)
N/A
|
0
N/A
|
4
+959%
|
7
+67%
|
3
-56%
|
2
-39%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
35
N/A
|
(18)
N/A
|
(18)
-3%
|
(13)
+31%
|
(8)
+33%
|
(7)
+19%
|
(5)
+30%
|
(4)
+19%
|
(3)
+20%
|
(1)
+74%
|
1
N/A
|
(4)
N/A
|
(1)
+65%
|
(1)
+41%
|
(4)
-354%
|
(2)
+44%
|
0
N/A
|
3
+5 728%
|
(1)
N/A
|
(2)
-123%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(14)
N/A
|
(19)
-35%
|
(19)
-2%
|
(13)
+30%
|
(9)
+31%
|
(7)
+27%
|
(6)
+12%
|
(6)
-3%
|
(4)
+37%
|
(0)
+89%
|
(1)
-75%
|
(6)
-648%
|
(7)
-23%
|
(6)
+9%
|
(4)
+44%
|
(2)
+31%
|
(4)
-56%
|
(3)
+18%
|
(4)
-19%
|
(4)
+1%
|
|
Switch to:
Switch to:
See Also
Discover More
